Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$3.41 USD
+0.83 (32.17%)
Updated Apr 30, 2024 03:59 PM ET
2-Buy of 5 2
A Value C Growth F Momentum B VGM
Income Statements
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 464 | 466 | 358 | 155 | 75 |
Cost Of Goods | 261 | 275 | 220 | 52 | 49 |
Gross Profit | 202 | 190 | 138 | 103 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 240 | 433 | 194 | 87 | 64 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Non-Operating Income | 31 | 63 | 85 | -164 | -119 |
Interest Expense | 39 | 31 | 17 | 4 | 3 |
Pretax Income | -46 | -210 | 12 | -152 | -159 |
Income Taxes | 47 | 45 | 29 | 24 | 5 |
Minority Interest | -7 | -10 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -93 | -255 | -17 | -176 | -164 |
Extras & Discontinued Operations | -186 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -272 | -245 | -17 | -176 | -164 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 53 | -151 | 4 | 35 | -27 |
Depreciation & Amortization (Cash Flow) | 90 | 92 | 60 | 19 | 10 |
Income After Depreciation & Amortization | -37 | -243 | -56 | 16 | -37 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.10 | 68.64 | 57.33 | 27.89 | NA |
Diluted EPS Before Non-Recurring Items | -1.16 | -1.42 | -0.92 | -0.44 | NA |
Diluted Net EPS (GAAP) | -3.68 | -3.58 | -0.30 | -6.32 | NA |
Fiscal Year end for Ayr Wellness Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 114.84 | 114.39 | 116.74 | 117.67 |
Cost Of Goods | NA | 65.45 | 66.26 | 60.09 | 69.38 |
Gross Profit | NA | 49.38 | 48.13 | 56.65 | 48.28 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 58.92 | 49.58 | 61.19 | 69.96 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -9.54 | -1.45 | -4.54 | -21.68 |
Non-Operating Income | NA | -0.40 | 6.50 | -3.28 | 28.04 |
Interest Expense | NA | 10.57 | 10.77 | 10.50 | 7.57 |
Pretax Income | NA | -20.51 | -5.73 | -18.32 | -1.21 |
Income Taxes | NA | 9.78 | 13.54 | 12.89 | 11.18 |
Minority Interest | NA | -2.31 | -1.02 | -0.71 | -3.03 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -30.29 | -19.27 | -31.20 | -12.38 |
Extras & Discontinued Operations | NA | -0.67 | -1.00 | 0.56 | -185.25 |
Net Income (GAAP) | NA | -28.65 | -19.25 | -29.93 | -194.60 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 76.95 | 76.56 | 72.76 | 70.01 |
Diluted EPS Before Non-Recurring Items | NA | -0.36 | -0.24 | -0.42 | -0.13 |
Diluted Net EPS (GAAP) | NA | -0.24 | -0.25 | -0.41 | -2.78 |